Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07634939 · ClinicalTrials.gov registry record

Liver Micro Flow - MRI

A clinical trial, sponsored by University of Wisconsin, Madison.

Not yet
Registry status
110
Enrollment target

NCT07634939 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 110 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07634939 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.

NOT YET RECRUITING
Registry status
110 participants
Enrollment target

Study Summary

This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these methods will be evaluated in 110 participants, including healthy volunteers, people with chronic liver disease (CLD), and people with liver fibrosis.

Interventions

  • DEVICE Novel MRI Software
  • OTHER Ensure Plus Nutrition Shake

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2026-07-01
Est. Completion 2029-05

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07634939

The ClinicalTrials.gov registry entry for NCT07634939 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Novel MRI Software is the first listed.

NCT07634939 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07634939 about?

NCT07634939 is a clinical study titled "Liver Micro Flow - MRI". This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstructure. The proposed perfusion and microstructure measures may provide biomarkers for fibrosis, cirrhosis, portal hypertension, and response to treatment. The precision of these metho...

What is the current status of trial NCT07634939?

This trial is currently not yet recruiting. The enrollment target is 110 participants. The study started on 2026-07-01. Estimated completion is 2029-05.

What interventions are being tested in trial NCT07634939?

The interventions under investigation include: Novel MRI Software (DEVICE), Ensure Plus Nutrition Shake (OTHER).

Who is sponsoring clinical trial NCT07634939?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.